Loading clinical trials...
Loading clinical trials...
An Open-Label Multiple-Dose Study of RZ358 in Patients With Congenital Hyperinsulinism
Conditions
Interventions
RZ358 Sequential Group Cohort 1
RZ358 Sequential Group Cohort 2
+2 more
Locations
17
United States
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Cook Children's Medical Center
Fort Worth, Texas, United States
SHAT Children diseases "Prof. Dr. Ivan Mitov"
Sofia, Bulgaria
Medical University of Varna UMHAT "St. Marina"
Varna, Bulgaria
Research Institute of the McGill University Health Centre
Monteral, Qubec, Canada
Odense University Hospital
Odense, Denmark
Start Date
February 24, 2020
Primary Completion Date
April 5, 2022
Completion Date
August 19, 2022
Last Updated
May 28, 2025
NCT02021604
NCT00674440
NCT01468454
NCT03042416
NCT03053284
NCT02533219
Lead Sponsor
Rezolute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions